Edit |   |
---|---|
Product Name | Adavosertib (MK-1775) |
Description | Adavosertib (MK-1775) is a small molecule which can act as a Wee1 checkpoint kinase inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: Cell cycle, DNA damage. This product may be interest in the following research areas and diseases: Ubiquitin/Proteasome, Cancer stem cells, Immunology, Cancer. Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. Purity > 98%. MW: 500.6 g/mol |
Size | 5 mg, 25 mg, |
Concentration | n/a |
Applications | n/a |
Other Names | Adavosertib (MK-1775), 1,2-Dihydro-1-[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]-6-[[4-(4-methyl-1-piperazinyl)-phenyl]amino]-2-(2-propen-1-yl)-3H-pyrazolo[3,4-d]pyrimidin-3-one, MK-1775; AZD 1775, 955365-80-7 |
Gene, Accession, CAS # | CAS: 955365-80-7 |
Catalog # | abx181672 |
Price | please inquire |
Order / More Info | Adavosertib (MK-1775) from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950